Merimepodib
- Generic Name
- Merimepodib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H24N4O6
- CAS Number
- 198821-22-6
- Unique Ingredient Identifier
- 2ZL2BA06FU
- Background
Merimepodib (VX-497) is a novel noncompetitive inhibitor of IMPDH. Merimepodib is orally bioavailable and inhibits the proliferation of primary human, mouse, rat, and dog lymphocytes at concentrations of approximately 100 nM.
- Indication
For the treatment of hepatitis C virus (HCV) infection.
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath